HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cell cycle phases of two human lung tumor cell lines derived from squamous cell carcinoma and pulmonary metastasis of a rhabdomyosarcoma (HS 24 and HS 57) and N-acetylalanine aminopeptidase activity.

Abstract
The cell cycle phase distribution of two human lung cancer cell lines (HS 24 and HS 57) grown both to half-confluency and confluency was determined. Both cell lines were then synchronized by applying a thymidine block forcing them to stay in the S-phase. After removal of the thymidine block, which allows the cells to go then through their cell cycle phases, N-acylamino acylpeptide hydrolase (EC 3.4.19.1) activity was measured using N-acetylalanine-p-nitroanilide as substrate (N-acetylalanine aminopeptidase). At the same times that the enzymatic activity was measured, the cell cycle phase distribution was analyzed, in order to determine the cell cycle phase of N-acetylalanine aminopeptidase synthesis. However, the cell cycle phase of N-acetylalanine aminopeptidase synthesis could not be determined. This result was caused by the fact that the cells remained synchronous only for a short period of time.
AuthorsO L Schoenberger, S Beikirch
JournalCancer biochemistry biophysics (Cancer Biochem Biophys) Vol. 10 Issue 4 Pg. 337-43 (Oct 1989) ISSN: 0305-7232 [Print] England
PMID2695238 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Neoplasm Proteins
  • Peptide Hydrolases
  • acylaminoacyl-peptidase
Topics
  • Carcinoma, Squamous Cell (enzymology, pathology)
  • Cell Cycle
  • Enzyme Induction
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Lung Neoplasms (enzymology, pathology, secondary)
  • Neoplasm Proteins (analysis)
  • Peptide Hydrolases (analysis)
  • Rhabdomyosarcoma (enzymology, pathology, secondary)
  • Tumor Cells, Cultured (enzymology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: